about
Stromal myofibroblasts in potentially malignant and malignant lesions of the oral cavity.Epidemiological and oral manifestations of HIV-positive patients in a specialized service in BrazilAgrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor PrognosisTWIST and p-Akt immunoexpression in normal oral epithelium, oral dysplasia and in oral squamous cell carcinoma.Overexpression of MutSα Complex Proteins Predicts Poor Prognosis in Oral Squamous Cell Carcinoma.IMRT delivers lower radiation doses to dental structures than 3DRT in head and neck cancer patients.Clinicopathological analysis of head and neck chondrosarcoma: three case reports and literature review.Myoepithelial carcinoma of the retromolar area with extensive mandibular involvement.Oral carcinoma cuniculatum: two cases illustrative of a diagnostic challenge.Polymorphous low-grade adenocarcinoma of the upper lip: 11 cases of an uncommon diagnosis.Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.Prognostic significance of hMSH2, hMSH3, and hMSH6 expression in ameloblastoma.Uncovering the role of brain-derived neurotrophic factor/tyrosine kinase receptor B signaling in head and neck malignancies.Clinical and genetic analysis of patients with cherubism.BRAF-V600E expression correlates with ameloblastoma aggressiveness.Effects of different radiation doses on the microhardness, superficial morphology, and mineral components of human enamel.Mismatch repair system proteins in oral benign and malignant lesions.Extensive Oral Mucormycosis in a Transplanted Patient.Current update on the diagnosis and management of head and neck hard tissue sarcomas.Distribution of oral and maxillofacial lesions in pediatric patients from a Brazilian southeastern population.Severe oral manifestation of dengue viral infection: a rare clinical description.Immunohistochemical Study of TGF-β1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma: Correlations Between Clinicopathologic Factors and Overall Survival.Ameloblastic carcinoma (secondary type) with extensive squamous differentiation areas and dedifferentiated regions.Transition from glass to digital slide microscopy in the teaching of oral pathology in a Brazilian dental school.Semaphorins and neuropilins expression in salivary gland tumors.Furuncular Myiasis Affecting the Lower Lip of a Young Patient.Immunoprofile of c-MET/PI3K signaling in human salivary gland tumors.Vascular endothelial growth factor immunoexpression is increased in malignant salivary gland tumors.Extranodal nasal NK/T-cell lymphoma: a rare oral presentation and FASN, CD44 and GLUT-1 expression.Immunoexpression of hoxb7 and hoxb9 in salivary gland tumours.P63 expression in papillary cystadenoma and mucoepidermoid carcinoma of minor salivary glands.Fine needle aspiration cytology and intralesional steroid injection in a central giant cell granuloma affecting the gingiva: a new clinical approach.Fine needle aspiration cytology in the diagnosis of perioral adverse reactions to cosmetic dermal fillers.Clinicopathologic analysis of 493 cases of salivary gland tumors in a Southern Brazilian population.Clinicopathological and immunohistochemical analysis of 19 cases of oral eosinophilic ulcers.CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma.Tissue microarray use for immunohistochemical study of ameloblastoma.Effect of 17-allylamino-17-demethoxygeldanamycin (17-AAG) on Akt protein expression is more effective in head and neck cancer cell lineages that retain PTEN protein expression.PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
P50
Q34993723-0B34721B-7AEC-4169-A549-1131E070B1B3Q35082242-ACA74B20-3865-46E5-B234-F1C4D3114910Q35519929-25C39426-1EFF-47AB-A8BC-B4AFF8434781Q35758658-EA3AEA37-3C75-4EC6-A05D-DC22119D124AQ36250713-CF1AC1B1-80ED-445C-B837-0475F1B66673Q36988709-B8E2183D-3BD5-437D-85B4-7BE7A6327104Q37240567-E4A80434-C2E3-4F44-843D-C7AC5D1CF448Q37953014-F06EB4EF-ECA1-4F9F-BB44-6A0DFE4C2DF8Q38045963-52B150E9-121C-4C89-85AF-CA49BE59249FQ38137488-72DAE327-9116-4B2E-9770-851289170AC5Q38369319-8189F718-3064-4BBB-AEC2-AD486D48D38CQ38492040-E2934A73-FDDA-4167-8366-12C17A8E9E75Q38666629-52C61854-9555-484F-A0A4-4498C57C6179Q38666650-1FD0FE33-1CFA-422A-BF2C-7EB0A8C057E5Q38712110-94BEAFA2-1D7F-4B8A-B452-4A7CDE53B1C0Q38816802-178D101D-C1F1-4AB8-BD4C-D65DD8789346Q38834315-E34E0B76-F14A-498C-B954-DC791DF424A1Q38923851-A25FF5D5-AF9A-47E5-B634-127AF74DD184Q39016768-DFF63891-7367-46EE-BC05-D85C2EDF7581Q39197993-D1B020EA-2360-4BA3-B76E-C2376C8BA759Q39301976-44CD66B7-F870-4CB9-A750-915D551F50D8Q39363510-42466344-7B22-47CA-9830-08E7C9B81222Q39909553-DAF34DC8-B87A-4DBF-A374-AFAE0ADC45A4Q40107527-45CF2E3E-F306-40B8-98B0-1344BF5F5797Q40215442-45A92827-8606-481C-A08A-2DC3DCA01378Q40298855-CF8C0B27-4B60-4CE2-9F8B-E5DA08AE4F73Q40407401-215600E1-0BB6-4CC7-9371-6525B3AEF921Q40790166-405BA591-C9CF-499B-BC7D-52619A46054BQ41031862-C716AD88-AD78-4D39-BF2D-425C51E7FE47Q42274896-79B6CC84-599A-4FC5-87C1-70551A13DD39Q42490655-B834B8D3-DE9B-4FF6-88FA-1A80E4E8E464Q42517542-F3189A37-6B3B-4C60-88ED-726CD9F641BEQ43641270-483BF55C-206B-4140-8E65-34747A343758Q44456728-C82E7B06-EB7C-4DE7-A207-EFD65757CEFBQ44643775-72934EFA-9389-4251-A418-75AD609B0203Q46422508-90F742CB-DBDA-420E-9FFD-AF42E02DE7FCQ46448653-D0AB4A94-C490-4F7E-BDB0-A466F2507D2DQ46798024-7B765330-2C8B-4755-9EDD-41B1CB69E52FQ47214666-67823092-EBAE-4D59-876C-24422FA54DE6Q47877197-C11C0F65-3F1D-4753-896B-7B8407F162D8
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
F P Fonseca
@en
F P Fonseca
@nl
type
label
F P Fonseca
@en
F P Fonseca
@nl
prefLabel
F P Fonseca
@en
F P Fonseca
@nl
P31
P496
0000-0002-6657-4547